Order Article Reprints

de Moura LD, Ribeiro LNM, de Carvalho FV, Rodrigues da Silva GH, Lima Fernandes PC, Brunetto SQ, Ramos CD, Velloso LA, de Araújo DR, de Paula E. Docetaxel and Lidocaine Co-Loaded (NLC-in-Hydrogel) Hybrid System Designed for the Treatment of Melanoma. Pharmaceutics. 2021; 13(10):1552. https://doi.org/10.3390/pharmaceutics13101552

de Moura, Ludmilla David, Lígia N. M. Ribeiro, Fabíola V. de Carvalho, Gustavo H. Rodrigues da Silva, Priscila C. Lima Fernandes, Sérgio Q. Brunetto, Celso D. Ramos, Lício A. Velloso, Daniele R. de Araújo, and Eneida de Paula. 2021. "Docetaxel and Lidocaine Co-Loaded (NLC-in-Hydrogel) Hybrid System Designed for the Treatment of Melanoma" Pharmaceutics 13, no. 10: 1552. https://doi.org/10.3390/pharmaceutics13101552

de Moura, L. D., Ribeiro, L. N. M., de Carvalho, F. V., Rodrigues da Silva, G. H., Lima Fernandes, P. C., Brunetto, S. Q., Ramos, C. D., Velloso, L. A., de Araújo, D. R., & de Paula, E. (2021). Docetaxel and Lidocaine Co-Loaded (NLC-in-Hydrogel) Hybrid System Designed for the Treatment of Melanoma. Pharmaceutics, 13(10), 1552. https://doi.org/10.3390/pharmaceutics13101552